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Abstract
Background: Post-hypoxic myoclonus (PHM) is a syndrome that occurs when a patient has suffered hypoxic brain injury. The myoclonus is usually multifocal and
generalized, often stemming from both cortical and subcortical origins. In severe cases, pharmacological treatments with antiepileptic medications may not
satisfactorily control the myoclonus.
Methods: We present a case of a 23-year-old male with chronic medication refractory PHM following a cardiopulmonary arrest related to an asthmatic attack
who improved with bilateral globus pallidus internus (GPi) deep brain stimulation (DBS). We review the clinical features of PHM, as well as the preoperative
and postoperative Unified Myoclonus Rating Scale scores and DBS programming parameters in this patient and compare them with the three other published
PHM-DBS cases in the literature.
Results: This patient experienced an alleviation of myoclonic jerks at rest and a 39% reduction in action myoclonus with improvement in both positive and
negative myoclonus with bilateral GPi-DBS. High frequency stimulation (130 Hz) with amplitudes .2.5 V were needed for the therapeutic response.
Discussion: We demonstrate a robust improvement in a medication refractory PHM patient with bilateral GPi-DBS, and suggest that it is a viable therapeutic
option for debilitating post-hypoxic myoclonus.
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Introduction
The syndrome of post-hypoxic myoclonus (PHM) emerges within days
to weeks of a patient suffering hypoxic brain injury, usually from cardio-
pulmonary arrest (CPA).1,2 PHM is commonly cortical, manifesting as
multifocal, generalized muscle jerks that increase during movement and/or
accentuate with sensory stimuli.3 Subcortical, brainstem myoclonus can
often coexist. First described by Lance and Adams,1 PHM can also be
associated with other neurological symptoms including cerebellar ataxia and
seizures. Myoclonus may be positive or negative, and patients usually have a
combination of cortical/subcortical and positive/negative myoclonus.
Treatment for chronic myoclonus is difficult, requiring a poly-
pharmacy approach using antiepileptic medications such as leviter-
acetam, piracetam, clonazepam, and valproate.4,5 Primidone, valproate,
and clonazepam are usually insufficient monotherapies and their side
effects can exacerbate the underlying myoclonus.6 Levetiracetam and
piracetam have been shown in clinical trials to be tolerable and
effective in cortical myoclonus,7,8 but the high doses needed for these
drugs can engender non-compliance. As a result, patients with
PHM usually require a combination of the classes of aforementioned
medications with variable responses. Deep brain stimulation (DBS) has
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been suggested in patients with chronic PHM, but there have been
only three reported cases of PHM treated with DBS.9–11 We report a
fourth case of a patient with PHM following an asthmatic attack and
CPA who was effectively treated with DBS, and only the second case
to utilize bilateral globus pallidus internus (GPi) stimulation. We
suggest that this approach should be considered in patients with severe
disability from PHM when medications fail.
Case
A 23-year-old male with a history of asthma and gastric bypass
surgery suffered an asthmatic attack en route to a scheduled endo-
scopy. He went into cardiopulmonary arrest and was resuscitated after
three rounds of defibrillation and cardiopulmonary resuscitation for
15 minutes. Within 24 hours of this event, he developed generalized
and multifocal myoclonus while in intensive care and was comatose
for approximately 1 month before regaining consciousness. Electro-
encephalogram monitoring did not reveal seizure activity. He under-
went a tracheostomy and a percutaneous endoscopic gastrostomy,
both of which were eventually reversed. He was referred to our center
2 years after the hypoxic and despite early gains in his mental status,
respiratory function and dysphagia, his myoclonus persisted—occurring
at rest and worsened with movement of his hands and legs. He was
unable to hold a cup with either hand because of action myoclonus
(Video 1). He required assistance with all activities of daily living and
was unable to ambulate more than a few steps even using a walker.
Throughout the day he had several episodes of myoclonic ‘‘volleys,’’
characterized as frequent, relentless flurries of generalized myoclonus
that would last 20 minutes to 1 hour (Video 2). The patient would
sweat profusely during these events and consumption of several shots
of vodka was found to substantially dampen the myoclonus. A regimen
of levetiracetam 1,500 mg twice a day, clonazepam 2 mg three times a
day, and valproate 250 mg three times a day provided only modest
control of his rest and action myoclonus and further increases failed to
decrease the severity or frequency of his myoclonic volleys.
On examination, while in the seated position, there were mild
spontaneous myoclonic jerks in his arms and hands. His speech was
incomprehensible with frequent arrests. He had one or two jerks of his
neck when rotating his head and infrequent facial myoclonus. Action
myoclonus emerged when his arms were outstretched and increased
on finger to nose movements with myoclonic jerks in flexor more than
extensor muscle groups. There was no stimulus-induced myoclonus
with tactile or pinprick stimulation of the arms or legs. He required
two-person assistance to stand, which triggered negative myoclonus in
his legs with frequent truncal jerks (Video 3). His stance was broad
based and he was unable to take a step forward.
Following a multidisciplinary deliberation that took into considera-
tion this patient’s preserved cognition, lack of other medical comor-
bidity, and severity of disability stemming from medication refractory
myoclonus, a recommendation for DBS was taken as an attempt to
recuperate some level of meaningful quality of life. The decision
to choose bilateral GPi as the target for implantation was in part based
on our experience along with published data of treating myoclonus in
myoclonus–dystonia patients with GPi-DBS.12–15
Methods
The patient underwent staged implantation of bilateral DBS electrodes
(Medtronic 3389, Medtronic Inc., St. Paul, MN) 3 years after his
anoxic event. The electrodes were placed into the posteroventrolateral
globus pallidus internus using a Leksell stereotactic frame and O-Arm
guidance. The operative target was localized as 20 mm lateral to the
Video 2. Myoclonic volley. Episode of myoclonic volley with frequent
generalized myoclonus at rest and with action.
Video 3. Myoclonus when standing. Negative myoclonus observed in the
patient’s legs when standing.
Video 1. Myoclonus at rest and with action. Cortical and subcortical
myoclonus affecting the patient’s speech and limb movements.
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midline, 2.5 mm anterior to the middle cerebral peduncle (MCP), and
4 mm inferior to the commissural line. The target was then cross
correlated with the reformatted Schaltenbrand and Wahren atlas and
with the Quantitative Susceptibility Mapping (QSM)16 images showing
the GPi. Intraoperative microelectrode recording provided further
targeting refinement and a postoperative CT co-registered with pre-
operative magnetic resonance imaging provided confirmation of
electrode placement (Figure 1).
Results
Postoperative programming commenced 2 weeks after the pulse
generators were implanted. Of note, there was no objective clinical
change in the patient’s physical condition or functional improvement
before stimulation started. Initial programming consisted of a mono-
polar review (pulse width (PW) 90 ms, frequency 130 Hz) that evaluated
each contact and mapped their myoclonus reduction along with any
unwanted side effects. There was immediate reduction of both rest and
action myoclonus, greater on the left hemibody during initial pro-
gramming. However, he developed an infection of the left implanted
pulse generator (IPG) 2 months from initial programming that spared
the left electrode. The IPG was removed, and as a result his right
upper extremity rest and action myoclonus returned. Following
6 weeks of antibiotics, his IPG was reimplanted.
Six months from the first programming session, there was only mild
action myoclonus in both his arms and legs. His lower extremity
negative myoclonus also showed improvement by this time following a
very modest rate of response up until that point. This allowed him to
stand by pushing off with both hands and walk several meters using a
walker in physical therapy with one-person assistance. He was able to
hold items with each hand, drink from a cup with one hand, and open
a bottle cap (Video 4). He started brushing his teeth independently and
assisted his caretakers with dressing and hygiene. In addition, his myo-
clonic volleys were no longer a daily occurrence.
Programming parameters and changes in his Unified Myoclonus
Rating Scale Motor scores from an unblinded rater are shown in Table 1
along with the three other published PHM-DBS cases. His action myo-
clonus in his arms required large stimulation amplitudes. Furthermore,
Figure 1. Bilateral DBS electrode position. Preoperative magnetic resonance imaging quantitative susceptibility mapping of coronal sequences showing the
co-registered postoperative computed tomography location of the centroid (red dot) of the left (A) and right (B) electrodes in the globus pallidus internus.
Video 4. 6 months after with Bilateral GPi-DBS. Reduction in
myoclonus with pallidal deep brain stimulation. The patient is able to drink
from a water bottle, push himself up to stand, and takes a few steps with
assistance.
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a tripolar configuration of the left DBS was used to create a broad stimula-
tion field as a means to attenuate his right upper extremity myoclonus.
As a result of reduced PHM, the patient’s underlying mild appen-
dicular dysmetria and gait ataxia, which were not initially appreciated
because of the extent of his muscle jerks, were unmasked, and remained
unresponsive to stimulation. His myoclonic medications also remained
unchanged as attempts to reduce them increased his myoclonus.
Discussion
Though neurophysiological studies were not conducted, phenom-
enologically this patient manifested both chronic cortical and sub-
cortical myoclonus. The presence of multifocal, distal muscle jerks that
increased with movement was consistent with a cortical process.
Subcortical or reticular myoclonus was evident with observed jerks in
his face, neck, and proximal upper extremity flexor muscles during
movement, as well as negative myoclonus in his legs.17,18
Pallidal and thalamic DBS have been shown to be quite effective
in suppressing myoclonus, especially in patients with myoclonus–
dystonia.12,13 However, to the best of our knowledge, there have only
been three reported cases of PHM treated with DBS (Table 1). Two
of those cases were pallidal stimulation—one of which was unilateral
to treat hemimyoclonus following a stroke,9 while the other was a
bilateral implantation that effectively treated CPA-induced myoclonus
in all extremities.11 Khobayashi et al.10 reported a case of perinatal
Table 2. Neuroimaging Findings in Post-Hypoxic Myoclonus
Study No. Patients Imaging
Modality
Results
Frucht et al.20 7 FDG-PET Bilateral increase in glucose metabolism in pontine tegmentum, ventrolateral
thalamus, and medial temporal lobes
Carbon et al.
21 7 FDG-PET Conjunction analysis with DYT-11 revealed shared increases in parasagittal
cerebellar nuclei bilaterally
Park et al.22,a 1 rs-fMRI Increased connectivity between:
1) primary motor cortex and right somatosensory association cortex
2) primary sensory cortex and left visual association cortex
3) supplementary motor cortex and right inferior temporal, right orbito-
temporal, left primary auditory, and left somatosensory association cortex
Ferlazzo et al.23 1 Serial MRIs 4 days after CPA, DWI lesions in cerebellum and thalami, FLAIR was normal
20 days after CPA–DWI and FLAIR normal
6 months after CPA–3T MRI with quantitative volumetric analysis no atrophy
of thalami, cerebellum, caudate nuclei, putamina, pallidus nuclei, hippocampi,
as well as normal volumes of whole encephalic tissue, gray and white matter
Werhahn et al.2,b 14 MRI Mean 2.5 years from CPA:
4 patients – mild cortical and cerebellar atrophy
4 patients – hemispheric or cerebellar infarcts
4 patients – normal
Zhang et al.24 2 SPECT
MRS
FDG-PET
1 patient 2 months from CPA
SPECT – revealed mild left temporal lobe hypoperfusion
1 patient 10 months from CPA
MRS – moderate reduction in N-acetyl aspartate peak in her left hippocampus
and a mild decrease in the right hippocampus
PET – metabolic reduction in frontal lobes
Huang et al.25 1 fMRI Increased BOLD bilateral cortical areas, particularly the motor cortex of legs.
Of note patient has only muscle jerks in her legs
Abbreviations: BOLD, Blood Oxygenation Level Dependent; CPA, Cardiopulmonary Arrest; DWI, Diffusion-weighted Image; FDG-PET,
[18F]-fludeoxyglucose-positron Emission Tomography; MRS, Magnetic Resonance Spectroscopy; PET, Positron Emission Tomography;
rs-fMRI, Resting State Functional Magnetic Resonance Imaging; SPECT - Single-photon emission computed tomography.
aOne post-hypoxic myoclonus patient compared with four age matched controls
b12 of 14 PHM patients had brain MRI.
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anoxia-induced action myoclonus successfully treated with bilateral
VIM-DBS. The programming parameters for these cases all utilized a
bipolar configuration to achieve therapeutic gain, whereas a mono-
polar and tripolar configuration in our patient, produced robust
responses at amplitudes .2.5 V without any side effects.
The pathophysiology of post-hypoxic myoclonus remains unknown.
However, the rat arrest model with myoclonus19 demonstrated degen-
eration in pyramidal cells of layers III and IV of the cerebral cortex
and reticular thalamus along with extensive Purkinje cell damage
in the cerebellum. Concomitantly, decreases in 5-HTP (hydroxytryp-
tophan), 5-HT (hydroxytryptamine receptors), and 5-HIAA (hydro-
xyindoleacetic acid) in the cortex, mesencephalic regions, striatum,
and cerebellum highlighted a potential role of the serotonergic system
in the pathophysiology of PHM. Recent human brain imaging studies
in PHM showed minimal anatomical changes but significant cortical
and cerebellar connectivity, metabolic, and blood flow changes2,20–25
(Table 2). Of note, fludeoxyglucose positron emission tomography
findings by Frucht and colleagues20 revealed elevated glucose meta-
bolism in the ventrolateral thalamus and pontine tegmentum in seven
patients with PHM, suggesting involvement of the basal ganglia-
thalamocortical network. When compared to myoclonus–dystonia
(DYT-11), shared metabolic increases were seen in the parasagittal
cerebellar nuclei.21 Combining these findings with the neuronal injury
in the paravermal and vermal regions of the rat arrest model, suggests
that dysfunctional ascending pathways intricate to motor execution19
are contributory to the generation of PHM. Furthermore, the unmask-
ing of cerebellar symptoms following attenuation of our patient’s myo-
clonus underscores the potential putative role of the cerebellum in the
pathogenesis of myoclonus, especially cortical myoclonus.
There are limited data regarding the neuronal activity of the GPi
in the context of PHM. However, aberrations in GPi neuronal
recordings have been reported in a constellation of hyperkinetic
disorders such as myoclonus–dystonia,26 generalized and secondary
dystonia, and hemiballismus.27,28 The response of cortical myoclo-
nus to pallidal stimulation in this patient suggests the possibility that
dysfunctional motor cortical relays and/or cerebellar efferents con-
verge on the basal ganglia–thalamocortical network triggering changes
in the nature of neuronal processing. Unlike cortical myoclonus, the
pathophysiology of subcortical myoclonus is less clear; however, its
response to stimulation infers a possible role for this network in its
pathogenesis.
In summary, we present a patient with medication-refractory post-
hypoxic myoclonus following cardiopulmonary arrest manifesting
with cortical (positive and negative myoclonus) and subcortical
myoclonus who experienced significant improvement with pallidal
deep brain stimulation. Based on our growing understanding of the
pathophysiology of cortical myoclonus as well as the robust nature
by which it responds to DBS in myoclonus–dystonia and a small
cohort of published PHM cases, it is not unreasonable to con-
sider DBS as a therapeutic option in debilitating Lance Adam’s
syndrome.
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